2024
DOI: 10.1101/2024.09.18.24312711
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Clinical validation of a DNA methylation biomarker to predict overall survival of relapsed ovarian cancer patients

Muhammad Habiburrahman,
Nahal Masrour,
Naina Patel
et al.

Abstract: Background: About 70% of ovarian cancer (OC) patients relapse after initial chemotherapy, making it crucial to predict survival before second-line treatment. Our previous work discovered a blood-based DNA methylation prognostic signature (PLAT-M8) that uses 8 CpG sites related to chemoresistance. We aim to validate this biomarker and its correlation with clinicopathological features and treatment profiles in additional cohorts. Methods: Extracted DNA from whole blood was provided from the BriTROC-1 (n=47) and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 96 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?